RT Journal Article
SR Electronic
T1 Development of a COVID-19 Application Ontology for the ACT Network
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.15.21253596
DO 10.1101/2021.03.15.21253596
A1 Shyam Visweswaran
A1 Malarkodi J. Samayamuthu
A1 Michele Morris
A1 Griffin M. Weber
A1 Douglas MacFadden
A1 Philip Trevvett
A1 Jeffrey G. Klann
A1 Vivian Gainer
A1 Barbara Benoit
A1 Shawn N. Murphy
A1 Lav Patel
A1 Nebojsa Mirkovic
A1 Yuliya Borovskiy
A1 Robert D. Johnson
A1 Matthew C. Wyatt
A1 Amy Y. Wang
A1 Robert W. Follett
A1 Ngan Chau
A1 Wenhong Zhu
A1 Mark Abajian
A1 Amy Chuang
A1 Neil Bahroos
A1 Phillip Reeder
A1 Donglu Xie
A1 Jennifer Cai
A1 Elaina R. Sendro
A1 Robert D. Toto
A1 Gary S. Firestein
A1 Lee M. Nadler
A1 Steven E. Reis
YR 2021
UL http://medrxiv.org/content/early/2021/04/14/2021.03.15.21253596.abstract
AB Clinical data networks that leverage large volumes of data in electronic health records (EHRs) are significant resources for research on coronavirus disease 2019 (COVID-19). Data harmonization is a key challenge in seamless use of multisite EHRs for COVID-19 research. We developed a COVID-19 application ontology in the national Accrual to Clinical Trials (ACT) network that enables harmonization of data elements that that are critical to COVID-19 research. The ontology contains over 50,000 concepts in the domains of diagnosis, procedures, medications, and laboratory tests. In particular, it has computational phenotypes to characterize the course of illness and outcomes, derived terms, and harmonized value sets for SARS-CoV-2 laboratory tests. The ontology was deployed and validated on the ACT COVID-19 network that consists of nine academic health centers with data on 14.5M patients. This ontology, which is freely available to the entire research community on GitHub at https://github.com/shyamvis/ACT-COVID-Ontology, will be useful for harmonizing EHRs for COVID-19 research beyond the ACT network.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under grant numbers UL1 TR000005-09S1 and UL1 TR001857-01S1, and by the National Library of Medicine of the National Institutes of Health under award numbers R01 LM012095. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research was approved by the University of Pittsburgh's IRB under protocol number STUDY19080059.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe ontology files are freely available at GitHub. https://github.com/shyamvis/ACT-COVID-Ontology